Eviso Quote - EVISO | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Italy
BIT
Eviso SPA (EVISO) Share Price

Eviso SPA (EVISO)

6.84

0.24

(3.64%)

Closed December 28 10:30AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

6.84

Bid

6.34

Ask

7.30

Volume

36,061

6.66 Day's Range 6.90

2.70 52 Week Range 6.90

Market Cap

Previous Close

6.60

Open

6.66

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

25,245

Shares Outstanding

24,655,992

Dividend Yield

0.66%

PE Ratio

0.00

Earnings Per Share (EPS)

-

Revenue

224.5M

Net Profit

4.88M

Sector

Electric Services

Industry

Electric Services

Website

www.eviso.it

Headquarters

Turin, Turin, Ita

Founded

-

Eviso SPA is listed in the Electric Services sector of the Italian Stock Exchange with ticker EVISO. The last closing price for Eviso was 6.60 €. Over the last year, Eviso shares have traded in a share price range of 2.70 € to 6.90 €.

Eviso currently has 24,655,992 shares outstanding. The market capitalization of Eviso is 162.73 € million.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.44	6.875	6.4	6.9	6.38	33270	6.5453794	DE
4	0.66	10.6796116505	6.18	6.9	6.1	22878	6.38739773	DE
12	1.22	21.7081850534	5.62	6.9	5.5	25245	6.15840141	DE
26	1.5	28.0898876404	5.34	6.9	4.27	24642	5.61574126	DE
52	4.1	149.635036496	2.74	6.9	2.7	34993	4.69841455	DE
156	4.3	169.291338583	2.54	6.9	2	26322	3.47734342	DE
260	4.84	242	2	6.9	1.89	34128	3.02068332	DE

EVISO - Frequently Asked Questions (FAQ)

What is the current Eviso share price?

The current share price of Eviso is 6.84 €

How many Eviso shares are in issue?

Eviso has 24,655,992 shares in issue

What is the market cap of Eviso?

The market capitalisation of Eviso is EUR 162.73M

What is the 1 year trading range for Eviso share price?

Eviso has traded in the range of 2.70 € to 6.90 € during the past year

What is the reporting currency for Eviso?

Eviso reports financial results in EUR

What is the latest annual turnover for Eviso?

The latest annual turnover of Eviso is EUR 224.5M

What is the latest annual profit for Eviso?

The latest annual profit of Eviso is EUR 4.88M

What is the registered address of Eviso?

The registered address for Eviso is VIA SILVIO PELLICO 19, 12037 SALUZZO, TURIN, TURIN

What is the Eviso website address?

The website address for Eviso is www.eviso.it

Which industry sector does Eviso operate in?

Eviso operates in the ELECTRIC SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WOSA25OSAI Automation System SpA	0.13 € (44.44%)	4.4k
WELESEles Spa	0.1289 € (28.77%)	25.8k
BIROEstrima Spa	0.276 € (21.05%)	274.4k
MNLMonnalisa SPA	1.45 € (18.85%)	277.37k
COSMOFarmacosmo spa	0.83 € (16.90%)	241.22k
WS3D25Solid World Group spa	0.19 € (-20.44%)	94.5k
WSGC28SG Company SpA	0.024 € (-18.37%)	5k
1KGXKion Group AG	31.83 € (-11.34%)	7
1CYTHLumen Technologies Inc	5.272 € (-9.99%)	3.25k
AIM2SEIF Spa	183.00 € (-5.84%)	30
TITTelecom Italia SpA	0.2452 € (1.32%)	144.28M
ISPIntesa Sanpaolo Spa	3.8635 € (1.14%)	41.32M
TITRTelecom Italia	0.2865 € (1.24%)	22.65M
SPMSaipem Spa	2.51 € (1.13%)	15.79M
ENELEnel Spa	6.83 € (0.46%)	15.77M

EmpressMonk25

EmpressMonk25 4 minutes ago

A valuation of $100 million suggests a narrative of success; therefore, given the nature of the patent for moving money, the actual value is far greater, reaching unprecedented levels. This patent appears to be revolutionary in the same way XRP seeks to move money. XRP method (same as patent describ

vuletini

vuletini 5 minutes ago

Patrick Bateman

Patrick Bateman 5 minutes ago

Why should it be .0008 rather than .0005

vuletini

vuletini 7 minutes ago

Nothing to get excited about....drop in the bucket

wingtrade

wingtrade 8 minutes ago

I doubt anybody could even sell $10K of stock at .0001 before there would be no bid on this

RUSTYJ

RUSTYJ 8 minutes ago

Learned my lesson years ago on this one

CherryTree1

CherryTree1 9 minutes ago

One would hope that once DCVAX-L for GBM is approved that Phase-3 trials for Direct would be much faster since we now know how the immune systems is engages with DCVAX-L. We shouldn't have to wait to see the long tail response over 5 or 6 years but could measure immune system cell response early on

NASDAQ2020

NASDAQ2020 10 minutes ago

This press release has the market size for Concerta in 2020:

https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-launches-generic-concerta-in-us-market/77906832

TheConcertabrand and generic market had U.S. sales of approximately USD $1.159 Billion

TenKay

TenKay 10 minutes ago

Well the original TSNP/Humbl deal left the legacy shareholders with 15% of the company equity after the Pref B were issued.

That dropped to less than 2% with the convertible debt dilution.

Foote is just going back to what he knows.

And nobody can actually

RobotDroid

RobotDroid 11 minutes ago

Not true, nwbo could have submitted a flawed document that has slowed approval to a crawl. Knowing how inept they are, it's a possibility.

dinogreeves

dinogreeves 12 minutes ago

It's not a gamble if you think SMCI will have filings in by February 25th.

skitahoe

skitahoe 12 minutes ago

I agree, and in the Q&A it's possible something new may come up, but much of the time the answer will be something like, it's too early for us to discuss this at this time.

When certain questions are answered I've often suspected that Analysts were specifically given suggestions on qu

wingtrade

wingtrade 12 minutes ago

This is a disaster lol

Hardazoak

Hardazoak 13 minutes ago

3 high grade gold mines acquired and paid for in full, 1 joint venture gold-silver mine that is currently in production and generating millions of dollars in revenue every quarter, 1 stockpile agreement worth 1.5 billion dollars signed and sealed, 1 top of the line massive labratory, 1 plant built t

SSKILLZ1

SSKILLZ1 13 minutes ago

Savvy Pick 10 Contest #1 Results In (Week 26)

Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057

SSKILLZ1

SSKILLZ1 13 minutes ago

Savvy Pick 10 Contest #1 Results In (Week 26)

Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057

dennisdave

dennisdave 14 minutes ago

Getting trials going will be critical to their ability to raise capital over the upcoming years as the -L MHRA story fades into the rear view mirror.
Your claim that NWBO could continue after DCVAXL has not been approved in the UK is BS, they cant it will end them guaranteed.

ronle

ronle 14 minutes ago

Thank you very much.

Huggy Bear

Huggy Bear 17 minutes ago

Shareholders are being raked over the coals, and not only are they totally unaware of what they really own, they are actually giddy about being fleeced.

With a little help from the usual suspects, of course.

Bull_Dolphin

Bull_Dolphin 18 minutes ago

This is a grown man? LOL

Large Green

Large Green 19 minutes ago

NDT, if this eight trillion was actually negative to JPM, their stock would have plummeted long before the filing was made public.

There is more to this however, there could be monies obfuscated of this huge amount that may find its way to those who signed timely releases by 3/2012.

SSKILLZ1

SSKILLZ1 19 minutes ago

Savvy Pick 10 Contest #1 (Week 26)

Congrats to our current leader LARRYBAZ up 85.49% so far in the contest. There are 23/27 portfolio up in the contest or 85.19%. So without any further ado the info. is below.
[pre]
Alias % Gain/Loss
1 LARRYB

Konaploinks

Konaploinks 20 minutes ago

You’re right. I’m thinking around 400 something , soon. If we don’t get taken over before that. Nvda ran to over 1,000 very quickly. Ionq has the patents Nvda needs to progress further. Also Msft. IBM. Google AWS. ETC ETC. EVERYONE has their eye on IonQ

NASDAQ2020

NASDAQ2020 20 minutes ago

Probably not our drug.
Our undisclosed CNS stimulant has overa Billion dollar market.

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions